Because SARS-CoV-2 enters human pulmonary cells by using angiotensin converting enzyme 2 (ACE2) as a receptor, there is serious concern about the adverse effects of hypertension as a condition contributing to the severity and poor prognosis of COVID-19. The gene discussed is ACE2; the disease is COVID-19.